During the past decade, Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)" are "Crohn's Disease" (1 trials), "Pulmonary Arterial Hypertension" (1 trials), "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials) and "Warm Autoimmune Hemolytic Anemia" (1 trials). Many other conditions were trialed in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)" in a lesser frequency.

Most popular intervention types in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Macitentan 10 mg" (2 trials), "FDC macitentan/tadalafil" (1 trials), "Golimumab" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu)". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacao para o Desenvolvimento Medico Hospitalar (UNESP Botucatu), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".